Modelling the hepatitis C virus epidemic in Australia

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 11, 1999, Pages 1100-1107

  Law, Matthew G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Epidemiology; Hepatitis C; Models

Indexed keywords

ARTICLE; AUSTRALIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; STATISTICAL MODEL; VIRUS TRANSMISSION;

EID: 0032756280     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.02014.x     Document Type: Article

References (30)

1. National Centre in HIV Epidemiology and Clinical Research (NCHECR). HIV/AIDS & Related Diseases in Australia. Annual Surveillance Report 1998. Sydney: NCHECR, 1998.
2. Sladden TJ, Hickey AR, Dunn TM, Beard JR. Hepatitis C transmission on the north coast of New South Wales: Explaining the unexplained. Med. J. Aust. 1997; 166: 290-3.
3. Selvey LA, Lush D, Mistry SA et al. Investigation of notifications of hepatitis C in 1994: The experience of three health departments. Aust. NZ J. Public Health 1996; 20: 525-9.
4. Garner JF, Gaughwin M, Dodding J, Willson K. Prevalence of hepatitis C infection in pregnant women in South Australia. Med. J. Aust. 1997; 166: 470-2.
5. Andrews R, Curran M, for the Communicable Diseases Network Australia New Zealand. Enhanced surveillance for incidence cases of hepatitis C in Australia, 1995. Commun. Dis. Intelligence. 1996; 20: 384-8.
6. Crofts N, Jolley D, Kaldor J, van Beck I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drugs users in Australia. J. Epidemiol. Comm. Health 1997; 6: 692-7.
7. Moaven LD, Crofts N, Locarnini SA. Hepatitis C virus in Victorian injecting drug users in 1971 (letter). Med. J. Aust. 1993; 158: 574.
8. Commonwealth Department of Health and Human Services. National Drug Strategy Household Survey. Survey Report 1995. Canberra: Australian Government Printing Service, 1996.
9. Hall W, Teesson M, Lynskey M, Gegenhardt L. The Prevalence in the Past Year of Substance Use and ICD-10 Substance Use Disorders in Australian Adults: Findings from the National Survey of Mental Health and Well-being. NDARC Technical Report no. 63, Sydney, 1998.
10. Dalkey NC. The Delphi Method: An Experimental Study of Group Opinion. Santa Monica: The RAND Corporation, RM-5888-PR, 1969.
11. Thorley A. Longitudinal studies of drug dependence. In: Edwards G, Busch C, eds. Drug Problems in Britain: A Review of TenYears. London: Academic Press, 1981.
12. English D, Holman CDJ, Milne E et al. The Quantification of Drug Caused Morbidity and Mortality in Australia, 1995 edn. Canberra: Commonwealth Department of Human Services and Health, 1995.
13. Li Y, Dorc GJ, Pritchard-Jones J, Kaldor J, McCaughan GW. Higher risk of cirrhosis among cases of 'sporadic' hepatitis C infection from countries of high background hepatitis C prevalence (abstract). In: Proceedings of First Australasian Conference on Hepatitis C, Sydney 1998.
14. Australian Bureau of Statistics. Deaths, Australia 1994. ABS Catalogue no. 3302.0. Canberra: Australian Government Printing Service, 1995.
15. Seeff LB. Natural history of hepatitis C. J. Hepatol. 1997; 26 (Suppl. 3); S21-8.
16. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 334: 1475-9.
17. Dore GJ, Kaldor JM, McCaughan GW. Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ 1997; 315: 333-7.
18. Resti M, Azzari C, Mannelli F et al. A mother to child transmission of hepatitis C virus: Prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ 1998; 317: 437-41.
19. Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-72.
20. Hepatitis C Virus Projections Working Group. Estimates and projections of the hepatitis C virus epidemic in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, 1998.
21. Crofts N, Hopper JL, Milner R, Bowden DS, Breschkin AM, Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med. J. Aust, 1993; 159: 237-41.
22. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 1991 94 (with projections to 1999). Cancer Series no. 7. Canberra: Australian Institute of Health and Welfare, 1998.
23. Brotodihardjo AE, Tait N, Weltman MD, Liddle C, Little JM, Farrell GC. Hepatocellular carcinoma in western Sydney: Aetiology, changes in incidence and opportunities for better outcomes. Med. J. Aust. 1994; 161: 433-5.
24. Thompson SC, Lin A, Warren R, Giles G, Crofts N. Risk factors associated with hepatocellular carcinoma notified to the Anti-Cancer Council of Victoria in 1991-92. Aust. NZ. J. Public Health 1997; 21: 626-30.
25. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
26. Alter HJ, Conry-Cantilena C, Melpolder J et al. Hepatitis C in asymptomatic blood donors. Hepatology 1997; 26 (Suppl. 3): S29-33.
27. Soto B, Sanchez-Quijano A, Rodrigo L et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J. Hepatol. 1997; 26: 1-5.
28. Ohlen J, Liegl JM, Sclmair H. Progression and natural history of chronic hepatitis B and C. Leber. Magen. Darm. 1995; 25: 205-10.
29. Telfer P, Sabin C, Devoreux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophiliac patients. Br. J. Haematol. 1994; 87: 555-61.
30. Rodger AJ, Thomson JA, Thompson SC et al. Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-75: Results of a pilot study. J. Gastroenterol. Hepatol. 1999; 14: 269-73.